Citation
Kell, Graham, et al. "Affron[®] a Novel Saffron Extract (Crocus Sativus L.) Improves Mood in Healthy Adults Over 4 Weeks in a Double-blind, Parallel, Randomized, Placebo-controlled Clinical Trial." Complementary Therapies in Medicine, vol. 33, 2017, pp. 58-64.
Kell G, Rao A, Beccaria G, et al. Affron[®] a novel saffron extract (Crocus sativus L.) improves mood in healthy adults over 4 weeks in a double-blind, parallel, randomized, placebo-controlled clinical trial. Complement Ther Med. 2017;33:58-64.
Kell, G., Rao, A., Beccaria, G., Clayton, P., Inarejos-García, A. M., & Prodanov, M. (2017). Affron[®] a novel saffron extract (Crocus sativus L.) improves mood in healthy adults over 4 weeks in a double-blind, parallel, randomized, placebo-controlled clinical trial. Complementary Therapies in Medicine, 33, 58-64. https://doi.org/10.1016/j.ctim.2017.06.001
Kell G, et al. Affron[®] a Novel Saffron Extract (Crocus Sativus L.) Improves Mood in Healthy Adults Over 4 Weeks in a Double-blind, Parallel, Randomized, Placebo-controlled Clinical Trial. Complement Ther Med. 2017;33:58-64. PubMed PMID: 28735826.
TY - JOUR
T1 - affron[®] a novel saffron extract (Crocus sativus L.) improves mood in healthy adults over 4 weeks in a double-blind, parallel, randomized, placebo-controlled clinical trial.
AU - Kell,Graham,
AU - Rao,Amanda,
AU - Beccaria,Gavin,
AU - Clayton,Paul,
AU - Inarejos-García,Antonio Manuel,
AU - Prodanov,Marin,
Y1 - 2017/06/13/
PY - 2017/02/03/received
PY - 2017/04/15/revised
PY - 2017/06/04/accepted
PY - 2017/7/25/entrez
PY - 2017/7/25/pubmed
PY - 2017/9/2/medline
KW - Clinical trial
KW - Depression
KW - Mood disorders
KW - Phytonutrient
KW - Saffron extract
SP - 58
EP - 64
JF - Complementary therapies in medicine
JO - Complement Ther Med
VL - 33
N2 - BACKGROUND: In recent years phytotherapy has been explored as a source for alternative treatments for mood disorders. One potential candidate is saffron (Crocus sativus L.), whose main bioactive components are crocins and safranal. OBJECTIVES: The aim of this study was to investigate the efficacy of affron[®], a standardised stigmas extract from Crocus sativus L. for improving mood, stress, anxiety and sleep quality in healthy adults. METHODS: In this 3 arm study, 128 participants self-reporting low mood but not diagnosed with depression, were given affron[®] at 28mg/day, 22mg/day, or a placebo treatment in a randomized, double-blind, placebo-controlled trial for 4 weeks. Mood was measured at baseline and at the end of the study, using the POMS (primary outcome measure) and PANAS questionnaires, and the DASS-21 scale. Sleep was monitored using Sleep Quality Index (PSQI). RESULTS: Analysis indicated a significant decrease in negative mood and symptoms related to stress and anxiety at a 28mg/day dose (with a significant difference between 28mg/day and placebo on the POMS Total Mood Disturbance scale, p<0.001, d=-1.10), but no treatment effect at the 22mg/day dose. LIMITATIONS: The main weaknesses of this investigation were found in the self-reporting nature of both the screening and the testing. CONCLUSIONS: affron[®] increased mood, reduced anxiety and managed stress without side effects, offering a natural alternative to standard treatments.
SN - 1873-6963
UR - https://neuro.unboundmedicine.com/medline/citation/28735826/affron[®]_a_novel_saffron_extract__Crocus_sativus_L___improves_mood_in_healthy_adults_over_4_weeks_in_a_double_blind_parallel_randomized_placebo_controlled_clinical_trial_
DB - PRIME
DP - Unbound Medicine
ER -